{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:32:26Z","timestamp":1762252346936},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11906-016-0644-7","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T09:18:53Z","timestamp":1460625533000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question)"],"prefix":"10.1007","volume":"18","author":[{"given":"Giorgina Barbara","family":"Piccoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranca","family":"Cabiddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Attini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Fassio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Loi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Gerbino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilisa","family":"Biolcati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonello","family":"Pani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tullia","family":"Todros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"issue":"11","key":"644_CR1","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2215\/CJN.10841210","volume":"6","author":"IF Nevis","year":"2011","unstructured":"Nevis IF, Reitsma A, Dominic A, et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol. 2011;6(11):2587\u201398.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 3","key":"644_CR2","doi-asserted-by":"crossref","first-page":"iii111","DOI":"10.1093\/ndt\/gfs302","volume":"27","author":"GB Piccoli","year":"2012","unstructured":"Piccoli GB, Fassio F, Attini R, et al. Pregnancy in CKD: whom should we follow and why? Nephrol Dial Transplant. 2012;27 Suppl 3:iii111\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"7637","key":"644_CR3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/bmj.39406.652986.BE","volume":"336","author":"D Williams","year":"2008","unstructured":"Williams D, Davison J. Chronic kidney disease in pregnancy. BMJ. 2008;336(7637):211\u20135.","journal-title":"BMJ"},{"issue":"3","key":"644_CR4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MNH.0000000000000119","volume":"24","author":"A Alkhunaizi","year":"2015","unstructured":"Alkhunaizi A, Melamed N, Hladunewich MA. Pregnancy in advanced chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens. 2015;24(3):252\u20139.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"644_CR5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jsgi.2004.05.002","volume":"11","author":"KP Conrad","year":"2004","unstructured":"Conrad KP. Mechanisms of renal vasodilation and hyperfiltration during pregnancy. J Soc Gynecol Investig. 2004;11(7):438\u201348.","journal-title":"J Soc Gynecol Investig"},{"issue":"1","key":"644_CR6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.mnh.0000436545.94132.52","volume":"23","author":"W Hussein","year":"2014","unstructured":"Hussein W, Lafayette RA. Renal function in normal and disordered pregnancy. Curr Opin Nephrol Hypertens. 2014;23(1):46\u201353.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"644_CR7","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1681\/ASN.2014050459","volume":"26","author":"GB Piccoli","year":"2015","unstructured":"Piccoli GB, Cabiddu G, Attini R, et al. Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol. 2015;26(8):2011\u201322. A large prospective cohort study, on over 500 singleton pregnancies, highlighting the risks of adverse pregnancy outcomes, in particular in those early CKD stages often considered as of lesser relevance with respect to pregnancy outcomes.","journal-title":"J Am Soc Nephrol"},{"key":"644_CR8","doi-asserted-by":"crossref","first-page":"g2301","DOI":"10.1136\/bmj.g2301","volume":"348","author":"K Bramham","year":"2014","unstructured":"Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:g2301. A comprehensive systematic review supporting counselling for hypertensive patients in pregnancy.","journal-title":"BMJ"},{"issue":"4","key":"644_CR9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/kisup.2013.76","volume":"3","author":"FG Hage","year":"2013","unstructured":"Hage FG, Mansur SJ, Xing D, Oparil S. Hypertension in women. Kidney Int Suppl (2011). 2013;3(4):352\u20136.","journal-title":"Kidney Int Suppl (2011)"},{"issue":"19","key":"644_CR10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","volume":"35","author":"SF Rimoldi","year":"2014","unstructured":"Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J. 2014;35(19):1245\u201354. A very useful review on secondary hypertension; not targeted on pregnancy may be of great help for interpretation of chronic hypertension in pregnant women.","journal-title":"Eur Heart J"},{"issue":"12","key":"644_CR11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113715","volume":"9","author":"TE Gillon","year":"2014","unstructured":"Gillon TE, Pels A, von Dadelszen P, MacDonell K, Magee LA. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS One. 2014;9(12), e113715. An interesting review, indirectly highlighting the many uncertainties in this field.","journal-title":"PLoS One"},{"issue":"6","key":"644_CR12","volume":"9","author":"C Ye","year":"2014","unstructured":"Ye C, Ruan Y, Zou L, et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes. PLoS One. 2014;9(6), e100180.","journal-title":"PLoS One"},{"issue":"11","key":"644_CR13","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCULATIONAHA.113.003904","volume":"129","author":"EW Seely","year":"2014","unstructured":"Seely EW, Ecker J. Chronic hypertension in pregnancy. Circulation. 2014;129(11):1254\u201361.","journal-title":"Circulation"},{"key":"644_CR14","volume-title":"Hypertension in pregnancy","author":"Committee on Hypertension in Pregnancy","year":"2013","unstructured":"Committee on Hypertension in Pregnancy. Hypertension in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2013."},{"issue":"5","key":"644_CR15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0272-6386(99)70413-0","volume":"33","author":"ND Vaziri","year":"1999","unstructured":"Vaziri ND. Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis. 1999;33(5):821\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"644_CR16","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2215\/CJN.00960208","volume":"3","author":"RJ Glassock","year":"2008","unstructured":"Glassock RJ, Winearls C. Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol. 2008;3(5):1563\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"644_CR17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5301\/JN.2011.7978","volume":"24","author":"GB Piccoli","year":"2011","unstructured":"Piccoli GB, Conijn A, Attini R, et al. Pregnancy in chronic kidney disease: need for a common language. J Nephrol. 2011;24(3):282\u201399.","journal-title":"J Nephrol"},{"issue":"3","key":"644_CR18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","volume":"64","author":"I Soveri","year":"2014","unstructured":"Soveri I, Berg UB, Bj\u00f6rk J, et al. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64(3):411\u201324.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"644_CR19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1933719110387831","volume":"18","author":"PM Koetje","year":"2011","unstructured":"Koetje PM, Spaan JJ, Kooman JP, Spaanderman ME, Peeters LL. Pregnancy reduces the accuracy of the estimated glomerular filtration rate based on Cockroft-Gault and MDRD formulas. Reprod Sci. 2011;18(5):456\u201362.","journal-title":"Reprod Sci"},{"issue":"10","key":"644_CR20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1055\/s-2007-986697","volume":"24","author":"AB Alper","year":"2007","unstructured":"Alper AB, Yi Y, Webber LS, et al. Estimation of glomerular filtration rate in preeclamptic patients. Am J Perinatol. 2007;24(10):569\u201374.","journal-title":"Am J Perinatol"},{"issue":"3","key":"644_CR21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.ackd.2013.01.012","volume":"20","author":"KL Cheung","year":"2013","unstructured":"Cheung KL, Lafayette RA. Renal physiology of pregnancy. Adv Chronic Kidney Dis. 2013;20(3):209\u201314. Clear and exhaustive pathophysiological review.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"7","key":"644_CR22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101897","volume":"9","author":"NH Morken","year":"2014","unstructured":"Morken NH, Travlos GS, Wilson RE, Eggesb\u00f8 M, Longnecker MP. Maternal glomerular filtration rate in pregnancy and fetal size. PLoS One. 2014;9(7), e101897.","journal-title":"PLoS One"},{"issue":"3","key":"644_CR23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/nep.12372","volume":"20","author":"GB Piccoli","year":"2015","unstructured":"Piccoli GB, Attini R, Vigotti FN, et al. Is renal hyperfiltration protective in chronic kidney disease-stage 1 pregnancies? A step forward unravelling the mystery of the effect of stage 1 chronic kidney disease on pregnancy outcomes. Nephrology (Carlton). 2015;20(3):201\u20138.","journal-title":"Nephrology (Carlton)"},{"issue":"12","key":"644_CR24","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3109\/14767058.2011.575483","volume":"24","author":"A Alsuwaida","year":"2011","unstructured":"Alsuwaida A, Mousa D, Al-Harbi A, Alghonaim M, Ghareeb S, Alrukhaimi MN. Impact of early chronic kidney disease on maternal and fetal outcomes of pregnancy. J Matern Fetal Neonatal Med. 2011;24(12):1432\u20136.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"7","key":"644_CR25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.semperi.2015.08.011","volume":"39","author":"SM Clark","year":"2015","unstructured":"Clark SM, Dunn HE, Hankins GD. A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy. Semin Perinatol. 2015;39(7):548\u201355.","journal-title":"Semin Perinatol"},{"issue":"1","key":"644_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajog.2015.04.013","volume":"213","author":"SMFM Publications Committee","year":"2015","unstructured":"SMFM Publications Committee. SMFM Statement: benefit of antihypertensive therapy for mild-to-moderate chronic hypertension during pregnancy remains uncertain. Am J Obstet Gynecol. 2015;213(1):3\u20134. A pivotal paper for chronic hypertension and pregnancy, particularly relevant for the assessment of side effects of \u201chyper\u201d correction.","journal-title":"Am J Obstet Gynecol"},{"issue":"23","key":"644_CR27","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1136\/heartjnl-2011-300949","volume":"97","author":"CW Redman","year":"2011","unstructured":"Redman CW. Hypertension in pregnancy: the NICE guidelines. Heart. 2011;97(23):1967\u20139.","journal-title":"Heart"},{"key":"644_CR28","doi-asserted-by":"crossref","first-page":"c2207","DOI":"10.1136\/bmj.c2207","volume":"341","author":"C Visintin","year":"2010","unstructured":"Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ. 2010;341:c2207.","journal-title":"BMJ"},{"issue":"3","key":"644_CR29","first-page":"241","volume":"4","author":"C Redman","year":"2014","unstructured":"Redman C. Pre-eclampsia: a complex and variable disease. Pregnancy Hypertens. 2014;4(3):241\u20132.","journal-title":"Pregnancy Hypertens"},{"issue":"4 Suppl","key":"644_CR30","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","volume":"213","author":"SJ Fisher","year":"2015","unstructured":"Fisher SJ. Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol. 2015;213(4 Suppl):S115\u201322.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"644_CR31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.preghy.2014.04.020","volume":"4","author":"C Redman","year":"2014","unstructured":"Redman C. The six stages of pre-eclampsia. Pregnancy Hypertens. 2014;4(3):246. A logic and pathophysiological approach to the development of PE; while it may not explain everything, it may be highly useful for the clinicians and the clinical researchers.","journal-title":"Pregnancy Hypertens"},{"issue":"4","key":"644_CR32","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","volume":"51","author":"LC Chappell","year":"2008","unstructured":"Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008;51(4):1002\u20139.","journal-title":"Hypertension"},{"issue":"1","key":"644_CR33","first-page":"93","volume":"78","author":"L Leeman","year":"2008","unstructured":"Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2008;78(1):93\u2013100.","journal-title":"Am Fam Physician"},{"key":"644_CR34","doi-asserted-by":"crossref","unstructured":"Panel discussion. Hypertension-management of hypertensive disorders of pregnancy according to international guidelines: a panel discussion (case 3: superimposed preeclampsia). Am J Perinatol. 2015. doi: 10.1055\/s-0035-1554844 .","DOI":"10.1055\/s-0035-1554844"},{"issue":"5","key":"644_CR35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062140","volume":"8","author":"E Lecarpentier","year":"2013","unstructured":"Lecarpentier E, Tsatsaris V, Goffinet F, Cabrol D, Sibai B, Haddad B. Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. PLoS One. 2013;8(5), e62140.","journal-title":"PLoS One"},{"issue":"8","key":"644_CR36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/OGX.0b013e3182331028","volume":"66","author":"D Raymond","year":"2011","unstructured":"Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497\u2013506.","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"644_CR37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/EDE.0000000000000039","volume":"25","author":"LM Bodnar","year":"2014","unstructured":"Bodnar LM, Simhan HN, Catov JM, et al. Maternal vitamin D status and the risk of mild and severe preeclampsia. Epidemiology. 2014;25(2):207\u201314.","journal-title":"Epidemiology"},{"issue":"2","key":"644_CR38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.preghy.2013.01.007","volume":"3","author":"N Steiner","year":"2013","unstructured":"Steiner N, Weintraub AY, Madi Y, Barski L, Sheiner E. The unfavorable slope from mild preeclampsia through severe preeclampsia, to eclampsia. Pregnancy Hypertens. 2013;3(2):146\u201350.","journal-title":"Pregnancy Hypertens"},{"issue":"2","key":"644_CR39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10641955.2013.784788","volume":"32","author":"S Rana","year":"2013","unstructured":"Rana S, Schnettler WT, Powe C, et al. Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy. 2013;32(2):189\u2013201. An interesting approach to the \u201cexceptions\u201d; useful in particular for those implementing biomarkers use in the clinical practice.","journal-title":"Hypertens Pregnancy"},{"key":"644_CR40","unstructured":"http:\/\/www.acog.org last accessed December 28th 2015."},{"key":"644_CR41","doi-asserted-by":"crossref","unstructured":"Piccoli GB, Minelli F, Versino E, et al. Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes. Nephrol Dial Transplant. 2015.","DOI":"10.1093\/ndt\/gfv395"},{"issue":"1","key":"644_CR42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2215\/CJN.05660809","volume":"5","author":"GB Piccoli","year":"2010","unstructured":"Piccoli GB, Conijn A, Consiglio V, et al. Pregnancy in dialysis patients: is the evidence strong enough to lead us to change our counseling policy? Clin J Am Soc Nephrol. 2010;5(1):62\u201371.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"644_CR43","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0706790","volume":"359","author":"BE Vikse","year":"2008","unstructured":"Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359(8):800\u20139.","journal-title":"N Engl J Med"},{"issue":"7","key":"644_CR44","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2215\/CJN.10641012","volume":"8","author":"MK Sandvik","year":"2013","unstructured":"Sandvik MK, Hallan S, Svarstad E, Vikse BE. Preeclampsia and prevalence of microalbuminuria 10 years later. Clin J Am Soc Nephrol. 2013;8(7):1126\u201334.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"644_CR45","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2009.12.036","volume":"55","author":"SD McDonald","year":"2010","unstructured":"McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis. 2010;55(6):1026\u201339.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"644_CR46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1408932","volume":"372","author":"AX Garg","year":"2015","unstructured":"Garg AX, Nevis IF, McArthur E, et al. Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med. 2015;372(2):124\u201333. A paper of great interest not only for clinicans involved in transplant care, but also as a model of the effect of \u201cminor\u201d forms of CKD.","journal-title":"N Engl J Med"},{"issue":"4","key":"644_CR47","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1600-6143.2009.02548.x","volume":"9","author":"HN Ibrahim","year":"2009","unstructured":"Ibrahim HN, Akkina SK, Leister E, et al. Pregnancy outcomes after kidney donation. Am J Transplant. 2009;9(4):825\u201334.","journal-title":"Am J Transplant"},{"issue":"4","key":"644_CR48","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1600-6143.2008.02427.x","volume":"9","author":"AV Reisaeter","year":"2009","unstructured":"Reisaeter AV, R\u00f8islien J, Henriksen T, Irgens LM, Hartmann A. Pregnancy and birth after kidney donation: the Norwegian experience. Am J Transplant. 2009;9(4):820\u20134.","journal-title":"Am J Transplant"},{"key":"644_CR49","doi-asserted-by":"crossref","first-page":"127083","DOI":"10.1155\/2015\/127083","volume":"2015","author":"A Rolfo","year":"2015","unstructured":"Rolfo A, Attini R, Tavassoli E, et al. Is it possible to differentiate chronic kidney disease and preeclampsia by means of new and old biomarkers? A prospective study. Dis Markers. 2015;2015:127083.","journal-title":"Dis Markers"},{"issue":"1","key":"644_CR50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ki.2012.348","volume":"83","author":"A Rolfo","year":"2013","unstructured":"Rolfo A, Attini R, Nuzzo AM, et al. Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers. Kidney Int. 2013;83(1):177\u201381.","journal-title":"Kidney Int"},{"issue":"5","key":"644_CR51","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/ndt\/gfs573","volume":"28","author":"GB Piccoli","year":"2013","unstructured":"Piccoli GB, Gaglioti P, Attini R, et al. Pre-eclampsia or chronic kidney disease? The flow hypothesis. Nephrol Dial Transplant. 2013;28(5):1199\u2013206.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"644_CR52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13\u201322. A paper that may represent a paradigm shift for the use of serum biomarkers in the diagnosis of PE.","journal-title":"N Engl J Med"},{"issue":"1","key":"644_CR53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJMe1515223","volume":"374","author":"EW Seely","year":"2016","unstructured":"Seely EW, Solomon CG. Improving the prediction of preeclampsia. N Engl J Med. 2016;374(1):83\u20134.","journal-title":"N Engl J Med"},{"issue":"2","key":"644_CR54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/j.ackd.2014.12.001","volume":"22","author":"E Judd","year":"2015","unstructured":"Judd E, Calhoun DA. Management of hypertension in CKD: beyond the guidelines. Adv Chronic Kidney Dis. 2015;22(2):116\u201322.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"644_CR55","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/HJH.0000000000000069","volume":"32","author":"KA Al Khaja","year":"2014","unstructured":"Al Khaja KA, Sequeira RP, Alkhaja AK, Damanhori AH. Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations. J Hypertens. 2014;32(3):454\u201363. A useful, extensive and critical review of old and new drugs.","journal-title":"J Hypertens"},{"issue":"2","key":"644_CR56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.ackd.2014.08.002","volume":"22","author":"A Hussain","year":"2015","unstructured":"Hussain A, Karovitch A, Carson MP. Blood pressure goals and treatment in pregnant patients with chronic kidney disease. Adv Chronic Kidney Dis. 2015;22(2):165\u20139. An important update on one of the most controversial issues in hypertensive pregnancies.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"644_CR57","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bpobgyn.2015.02.005","volume":"29","author":"GB Piccoli","year":"2015","unstructured":"Piccoli GB, Cabiddu G, Attini R, et al. Pregnancy in chronic kidney disease: questions and answers in a changing panorama. Best Pract Res Clin Obstet Gynaecol. 2015;29(5):625\u201342.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"644_CR58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40265-014-0187-7","volume":"74","author":"CM Brown","year":"2014","unstructured":"Brown CM, Garovic VD. Drug treatment of hypertension in pregnancy. Drugs. 2014;74(3):283\u201396.","journal-title":"Drugs"},{"issue":"1","key":"644_CR59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semnephrol.2010.10.007","volume":"31","author":"T Podymow","year":"2011","unstructured":"Podymow T, August P. Antihypertensive drugs in pregnancy. Semin Nephrol. 2011;31(1):70\u201385.","journal-title":"Semin Nephrol"},{"issue":"8","key":"644_CR60","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/j.semperi.2014.08.016","volume":"38","author":"TR Easterling","year":"2014","unstructured":"Easterling TR. Pharmacological management of hypertension in pregnancy. Semin Perinatol. 2014;38(8):487\u201395.","journal-title":"Semin Perinatol"},{"key":"644_CR61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.0954-6820.1979.tb00788.x","volume":"628","author":"G Holm","year":"1979","unstructured":"Holm G. Immunological side-effects of antihypertensive drugs. Acta Med Scand Suppl. 1979;628:85\u20138.","journal-title":"Acta Med Scand Suppl"},{"issue":"1","key":"644_CR62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00403-008-0895-5","volume":"301","author":"CD Vedove","year":"2009","unstructured":"Vedove CD, Del Giglio M, Schena D, Girolomoni G. Drug-induced lupus erythematosus. Arch Dermatol Res. 2009;301(1):99\u2013105.","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"644_CR63","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.ijcard.2007.07.034","volume":"130","author":"P Gatault","year":"2008","unstructured":"Gatault P, Genee O, Legras A, Garot D, Mercier E, Fichet J. Calcium-channel blockers: an increasing cause of pulmonary edema during tocolytic therapy. Int J Cardiol. 2008;130(3):e123\u20134.","journal-title":"Int J Cardiol"},{"issue":"2","key":"644_CR64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijgo.2007.01.011","volume":"97","author":"AH Nassar","year":"2007","unstructured":"Nassar AH, Ghazeeri G, Usta IM. Nifedipine-associated pulmonary complications in pregnancy. Int J Gynaecol Obstet. 2007;97(2):148\u20139.","journal-title":"Int J Gynaecol Obstet"},{"issue":"10","key":"644_CR65","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.jhh.1001248","volume":"15","author":"A Sirker","year":"2001","unstructured":"Sirker A, Missouris CG, MacGregor GA. Dihydropyridine calcium channel blockers and peripheral side effects. J Hum Hypertens. 2001;15(10):745\u20136.","journal-title":"J Hum Hypertens"},{"issue":"5","key":"644_CR66","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1524-6175.2003.02216.x","volume":"5","author":"MR Weir","year":"2003","unstructured":"Weir MR. Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance. J Clin Hypertens (Greenwich). 2003;5(5):330\u20135.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"644_CR67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/j.1875-9114.1983.tb03252.x","volume":"3","author":"EP MacCarthy","year":"1983","unstructured":"MacCarthy EP, Bloomfield SS. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy. 1983;3(4):193\u2013219.","journal-title":"Pharmacotherapy"},{"key":"644_CR68","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejogrb.2014.01.019","volume":"175","author":"RH Xie","year":"2014","unstructured":"Xie RH, Guo Y, Krewski D, et al. Association between labetalol use for hypertension in pregnancy and adverse infant outcomes. Eur J Obstet Gynecol Reprod Biol. 2014;175:124\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"644_CR69","unstructured":"www.fda.org last accessed January 1st 2016."},{"issue":"12","key":"644_CR70","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1093\/ndt\/gfp320","volume":"24","author":"J Munkhaugen","year":"2009","unstructured":"Munkhaugen J, Lydersen S, Romundstad PR, Wider\u00f8e TE, Vikse BE, Hallan S. Kidney function and future risk for adverse pregnancy outcomes: a population-based study from HUNT II, Norway. Nephrol Dial Transplant. 2009;24(12):3744\u201350.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"644_CR71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/kisup.2012.46","volume":"2","author":"KDIGO","year":"2012","unstructured":"KDIGO. Clinical practice guideline for the evaluation and management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2(5):337\u2013414.","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"644_CR72","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.ajkd.2013.03.018","volume":"62","author":"SJ Taler","year":"2013","unstructured":"Taler SJ, Agarwal R, Bakris GL, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis. 2013;62(2):201\u201313.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"644_CR73","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-154-8-201104190-00335","volume":"154","author":"A Upadhyay","year":"2011","unstructured":"Upadhyay A, Earley A, Haynes SM, Uhlig K. Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med. 2011;154(8):541\u20138.","journal-title":"Ann Intern Med"},{"issue":"4","key":"644_CR74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-159-4-201308200-00004","volume":"159","author":"CP Kovesdy","year":"2013","unstructured":"Kovesdy CP, Bleyer AJ, Molnar MZ, et al. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med. 2013;159(4):233\u201342.","journal-title":"Ann Intern Med"},{"issue":"4","key":"644_CR75","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/HCO.0b013e32836208c2","volume":"28","author":"SB Nicholas","year":"2013","unstructured":"Nicholas SB, Vaziri ND, Norris KC. What should be the blood pressure target for patients with chronic kidney disease? Curr Opin Cardiol. 2013;28(4):439\u201345.","journal-title":"Curr Opin Cardiol"},{"issue":"5","key":"644_CR76","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/AOG.0000000000000205","volume":"123","author":"NA Ankumah","year":"2014","unstructured":"Ankumah NA, Cantu J, Jauk V, et al. Risk of adverse pregnancy outcomes in women with mild chronic hypertension before 20 weeks of gestation. Obstet Gynecol. 2014;123(5):966\u201372. An interesting paper suggesting that the effect of hypertension, even if mild, is relevant and that there is a strong direct relationship between blood pressure levels and outcomes, even in the area of \u201cmild\u201d hypertension.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"644_CR77","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/jch.12614","volume":"17","author":"AF Cicero","year":"2015","unstructured":"Cicero AF, Degli Esposti D, Immordino V, et al. Independent determinants of maternal and fetal outcomes in a sample of pregnant outpatients with normal blood pressure, chronic hypertension, gestational hypertension, and preeclampsia. J Clin Hypertens (Greenwich). 2015;17(10):777\u201382.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"644_CR78","doi-asserted-by":"crossref","first-page":"260.e1","DOI":"10.1016\/j.ajog.2011.06.033","volume":"205","author":"MO Cruz","year":"2011","unstructured":"Cruz MO, Gao W, Hibbard JU. Obstetrical and perinatal outcomes among women with gestational hypertension, mild preeclampsia, and mild chronic hypertension. Am J Obstet Gynecol. 2011;205(3):260.e1\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"644_CR79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MNH.0000000000000105","volume":"24","author":"M Sircar","year":"2015","unstructured":"Sircar M, Thadhani R, Karumanchi SA. Pathogenesis of preeclampsia. Curr Opin Nephrol Hypertens. 2015;24(2):131\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"644_CR80","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2215\/CJN.07911109","volume":"5","author":"GB Piccoli","year":"2010","unstructured":"Piccoli GB, Attini R, Vasario E, et al. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol. 2010;5(5):844\u201355.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"644_CR81","first-page":"647","volume":"48","author":"R Christianson","year":"1976","unstructured":"Christianson R, Page EW. Diuretic drugs and pregnancy. Obstet Gynecol. 1976;48(6):647\u201352.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"644_CR82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0020-7292(97)00234-8","volume":"60","author":"DR Hall","year":"1998","unstructured":"Hall DR, Odendaal HJ. The addition of a diuretic to anti-hypertensive therapy for early severe hypertension in pregnancy. Int J Gynaecol Obstet. 1998;60(1):63\u20134.","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"644_CR83","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.semnephrol.2014.08.011","volume":"34","author":"VM Campese","year":"2014","unstructured":"Campese VM. Pathophysiology of resistant hypertension in chronic kidney disease. Semin Nephrol. 2014;34(5):571\u20136. Bright and clear, this review analyses old and new issues on resistant hypertension.","journal-title":"Semin Nephrol"},{"issue":"5","key":"644_CR84","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40265-015-0372-3","volume":"75","author":"D Glicklich","year":"2015","unstructured":"Glicklich D, Frishman WH. Drug therapy of apparent treatment-resistant hypertension: focus on mineralocorticoid receptor antagonists. Drugs. 2015;75(5):473\u201385.","journal-title":"Drugs"},{"issue":"6","key":"644_CR85","first-page":"575","volume":"19","author":"DC Brater","year":"1999","unstructured":"Brater DC. Use of diuretics in cirrhosis and nephrotic syndrome. Semin Nephrol. 1999;19(6):575\u201380.","journal-title":"Semin Nephrol"},{"key":"644_CR86","doi-asserted-by":"crossref","unstructured":"Mathen S, Venning M, Gillham J. Outpatient management of Gitelman's syndrome in pregnancy. BMJ Case Rep. 2013;2013.","DOI":"10.1136\/bcr-2012-007927"},{"issue":"2","key":"644_CR87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcrc.2013.10.004","volume":"29","author":"GD Kitsios","year":"2014","unstructured":"Kitsios GD, Mascari P, Ettunsi R, Gray AW. Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis. J Crit Care. 2014;29(2):253\u20139.","journal-title":"J Crit Care"},{"issue":"4","key":"644_CR88","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/cells4040622","volume":"4","author":"M Duffy","year":"2015","unstructured":"Duffy M, Jain S, Harrell N, Kothari N, Reddi AS. Albumin and furosemide combination for management of edema in nephrotic syndrome: a review of clinical studies. Cells. 2015;4(4):622\u201330.","journal-title":"Cells"},{"issue":"4","key":"644_CR89","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0022-3476(86)80222-0","volume":"109","author":"W Rascher","year":"1986","unstructured":"Rascher W, Tulassay T, Seyberth HW, Himbert U, Lang U, Sch\u00e4rer K. Diuretic and hormonal responses to head-out water immersion in nephrotic syndrome. J Pediatr. 1986;109(4):609\u201314.","journal-title":"J Pediatr"},{"issue":"5 Pt 1","key":"644_CR90","first-page":"726","volume":"94","author":"T Kent","year":"1999","unstructured":"Kent T, Gregor J, Deardorff L, Katz V. Edema of pregnancy: a comparison of water aerobics and static immersion. Obstet Gynecol. 1999;94(5 Pt 1):726\u20139.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"644_CR91","first-page":"147","volume":"75","author":"VL Katz","year":"1990","unstructured":"Katz VL, Ryder RM, Cefalo RC, Carmichael SC, Goolsby R. A comparison of bed rest and immersion for treating the edema of pregnancy. Obstet Gynecol. 1990;75(2):147\u201351.","journal-title":"Obstet Gynecol"},{"key":"644_CR92","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1681\/ASN.V391575","volume":"3","author":"PG Pryde","year":"1993","unstructured":"Pryde PG, Sedman AB, Nugent CE, Barr Jr M. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol. 1993;3:1575\u201382.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"644_CR93","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jpeds.2015.05.045","volume":"167","author":"S Nadeem","year":"2015","unstructured":"Nadeem S, Hashmat S, Defreitas MJ, et al. Renin angiotensin system blocker fetopathy: a Midwest Pediatric Nephrology Consortium report. J Pediatr. 2015;167(4):881\u20135. Interesting paper providing information on extrarenal, lesser known, malformations.","journal-title":"J Pediatr"},{"issue":"2","key":"644_CR94","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/17512433.2015.1005074","volume":"8","author":"M Pucci","year":"2015","unstructured":"Pucci M, Sarween N, Knox E, Lipkin G, Martin U. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits. Expert Rev Clin Pharmacol. 2015;8(2):221\u201331.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"8","key":"644_CR95","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/bdra.23027","volume":"94","author":"JE Polifka","year":"2012","unstructured":"Polifka JE. Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence. Birth Defects Res A Clin Mol Teratol. 2012;94(8):576\u201398.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"5 Suppl","key":"644_CR96","doi-asserted-by":"crossref","first-page":"1285S","DOI":"10.1093\/ajcn\/71.5.1285s","volume":"71","author":"PJ Steer","year":"2000","unstructured":"Steer PJ. Maternal hemoglobin concentration and birth weight. Am J Clin Nutr. 2000;71(5 Suppl):1285S\u20137.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"644_CR97","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.ajkd.2012.07.014","volume":"61","author":"I Koulouridis","year":"2013","unstructured":"Koulouridis I, Alfayez M, Trikalinos TA, Balk EM, Jaber BL. Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis. Am J Kidney Dis. 2013;61(1):44\u201356. An important paper on the adverse effects of ESAs, potentially translated to pregnancy.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"644_CR98","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00041552-200109000-00013","volume":"10","author":"ND Vaziri","year":"2001","unstructured":"Vaziri ND. Cardiovascular effects of erythropoietin and anemia correction. Curr Opin Nephrol Hypertens. 2001;10(5):633\u20137.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"644_CR99","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s004040100234","volume":"267","author":"M Kashiwagi","year":"2002","unstructured":"Kashiwagi M, Breymann C, Huch R, Huch A. Hypertension in a pregnancy with renal anemia after recombinant human erythropoietin (rhEPO) therapy. Arch Gynecol Obstet. 2002;267(1):54\u20136.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"644_CR100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ndt\/gfg517","volume":"19","author":"G Piccoli","year":"2004","unstructured":"Piccoli G, Bontempo S, Mezza E, et al. Sudden development of low tolerance of dialysis in a young female patient. Nephrol Dial Transplant. 2004;19(1):255\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"644_CR101","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40620-015-0191-3","volume":"28","author":"G Cabiddu","year":"2015","unstructured":"Cabiddu G, Castellino S, Gernone G, Kidney and Pregnancy Study Group of Italian Society of Nephrology, et al. Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy. J Nephrol. 2015;28(3):279\u201388. One of the few (and the only recent one) best practice guidelines for pregnancy and dialysis.","journal-title":"J Nephrol"},{"issue":"4","key":"644_CR102","first-page":"297","volume":"49","author":"GG Nahum","year":"2004","unstructured":"Nahum GG, Stanislaw H. Hemoglobin, altitude and birth weight: does maternal anemia during pregnancy influence fetal growth? J Reprod Med. 2004;49(4):297\u2013305.","journal-title":"J Reprod Med"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-016-0644-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-016-0644-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-016-0644-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T19:06:13Z","timestamp":1718478373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-016-0644-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["644"],"URL":"https:\/\/doi.org\/10.1007\/s11906-016-0644-7","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,12]]},"article-number":"35"}}